References
- Gumy-Pause F, Wacker P, Sappino A P. ATM gene and lymphoid malignancies. Leukemia 2004; 18: 238–242
- Kaneko H, Kondo N. Clinical features of Bloom syndrome and function of the causative gene, BLM helicase. Expert Rev Mol Diagn 2004; 4: 393–401
- van der Burgt I, Chrzanowska K H, Smeets D, Weemaes C. Nijmegen breakage syndrome. J Med Genet 1996; 33: 153–156
- Ward J M, Devor-Henneman D E. Mouse models of human familial cancer syndromes. Toxicol Pathol 2004; 32(Suppl. 1)90–98
- Kotoula V, Hytiroglou P, Kaloutsi V, Barbanis S, Kouidou S, Papadimitriou C S. Mismatch repair gene expression in malignant lymphoproliferative disorders of B-cell origin. Leuk Lymphoma 2002; 43: 393–399
- Teruya-Feldstein J, Greene J, Cohen L, Popplewell L, Ellis N A, Offit K. Analysis of mismatch repair defects in the familial occurrence of lymphoma and colorectal cancer. Leuk Lymphoma 2002; 43: 1619–1626
- Bianco T, Chenevix-Trench G, Walsh D C, Cooper J E, Dobrovic A. Tumour-specific distribution of BRCA1 promoter region methylation supports a pathogenetic role in breast and ovarian cancer. Carcinogenesis 2000; 21: 147–151
- Chim C S, Wong K Y, Loong F, Srivastava G. Absence of ATM hypermethylation in mantle cell and follicular lymphoma. Leukemia 2005; 19: 880–882
- Hegi M E, Diserens A C, Gorlia T, Hamou M F, de Tribolet N, Weller M, et al. MGMT gene silencing and benefit from temozolomide in glioblastoma. N Engl J Med 2005; 352: 997–1003
- Esteller M, Gaidano G, Goodman S N, Zagonel V, Capello D, Botto B, et al. Hypermethylation of the DNA repair gene O(6)-methylguanine DNA methyltransferase and survival of patients with diffuse large B-cell lymphoma. J Natl Cancer Inst 2002; 94: 26–32
- Nandi S, Yu J, Burger A M, Reinert L S, Gartenhaus R B. Expression of DNA mismatch repair proteins in transformed non-Hodgkin's lymphoma: Relationship to smoking. Leuk Lymphoma 2006; 47: 1806–1812
- Fulop Z, Csernus B, Timar B, Szepesi A, Matolcsy A. Microsatellite instability and hMLH1 promoter hypermethylation in Richter's transformation of chronic lymphocytic leukemia. Leukemia 2003; 17: 411–415
- Plumb J A, Strathdee G, Sludden J, Kaye S B, Brown R. Reversal of drug resistance in human tumor xenografts by 2'-deoxy-5-azacytidine-induced demethylation of the hMLH1 gene promoter. Cancer Res 2000; 60: 6039–6044
- Oki Y, McLaughlin P, Pro B, Hagemeister F B, Bleyer A, Loyer E, et al. Phase II study of oxaliplatin in patients with recurrent or refractory non-Hodgkin lymphoma. Cancer 2005; 104: 781–787
- Alinari L, Musuraca G, Tani M, Stefoni V, Gabriele A, Marchi E, et al. Value of oxaliplatin treatment in heavily pretreated patients with non-Hodgkin's lymphoma. Leuk Lymphoma 2005; 46: 1437–1440